CORPORATE GOVERNANCE REPORT

1. Name of Listed Entity - Dr. Reddy's Laboratories Limited

2. Quarter ending

- 31 March 2023

  1. Whether the Listed entity has a regular chairperson - Yes
  2. Whether Chairperson is related to MD or CEO - No(1)

I. Composition of Board of Directors

Titl

Name of the

DIN

PAN

Category

Date of

Date of

Initial

Date of re-

Date of

Tenure

No of

No of

No of

No of post of

e

Director

(Chairperson

Birth

Special

date of

appointme

cessation

(in

Directors

Independe

memberships

Chairperson

(Mr.

/Executive/N

Resoluti

Appoint

nt

months)

hip in

nt

in Audit/

in Audit/

/Ms

on-

on under

ment

listed

Directorshi

Stakeholder

Stakeholder

)

Executive/

Reg.

entities

p in listed

Committee(s

Committee

Independent/

17(1A)

including

entities

) including

held in listed

Nominee)

of

this

including

this listed

entities

Listing

listed

this listed

entity

including

Regs

entity

entity

this listed

entity(3)

Mr.

K Satish

00129701

AERPK6948L

Chairman

09.06.67

NA

18.01.93

01.10.17

-

1

0

1

0

Reddy

Mr.

G V Prasad

00057433

AAHPP9553C

Co-

22.11.60

NA

08.04.86

30.01.21

-

1

0

1

0

Chairman &

MD

Ms.

Kalpana

00046081

AAGPM5926M

Independent

30.05.49

30.07.19

05.06.07

31.07.19

-

104

2

2

3

2

Morparia

Director

Mr.

Sridar

00278512

AACPI7514D

Independent

13.08.47

30.07.19

22.08.11

31.07.19

-

104

2

2

3

2

Iyengar

Director

Mr.

Leo Puri

01764813

AALPP0852A

Independent

03.01.61

NA

25.10.18

-

-

53.00

2

2

1

0

Director

Ms.

Shikha

00043265

ALFPS9244J

Independent

19.11.58

NA

31.01.19

-

-

50.00

5

4

3

0

Sharma

Director

Mr.

Allan

08393837

ZZZZZ9999Z

Independent

29.08.57

NA

26.03.19

-

-

45.00

0

0

0

0

Oberman(2)

Director

Dr.

K P

01099097

AAEPK6039K

Independent

29.12.59

NA

07.01.22

07.01.22

-

15.00

2

2

2

1

Krishnan

Director

Ms.

Penny

09479493

ZZZZZ9999Z

Independent

13.12.65

NA

28.01.22

28.01.22

-

14.00

1

1

0

0

Wan(2)

Director

Mr.

Arun

09665138

ZZZZZ9999Z

Independent

25.11.52

NA

01.08.22

01.08.22

-

8.00

1

1

1

0

Madhavan

Director

Kumar(2)

Notes:

1.Mr. K Satish Reddy (Chairman) and Mr. G V Prasad (Co-Chairman and MD) are not relatives as per the definition of the term 'relative' defined under the Companies Act, 2013. However, Mr. K Satish Reddy and Mr. G V Prasad are brothers-in-law.

2.Mr. Allan Grant Oberman, Ms. Penny Wan and Mr Arun Madhavan Kumar, being foreign nationals, do not have PAN. Hence their PAN no. is entered as ZZZZZ9999Z, as suggested by the exchanges earlier.

3.Committee Chairmanship includes Committee Membership.

KUMAR RANDHIR SINGH

Digitally signed by

KUMAR RANDHIR SINGH Date: 2023.04.20 17:20:49 +05'30'

  1. Composition of Committees

Audit Committee

Whether the Audit Committee has a regular chairperson - Yes

Sr.

Name of the Director

Category

Chairperson/Membership

Date of Appointment

Date of Cessation

Remarks

No.

1

Sridar Iyengar

Independent Director

Chairperson

22-Aug-2011

-

-

2

Shikha Sharma

Independent Director

Member

31-Jan-2019

-

-

3

Kalpana Morparia

Independent Director

Member

02-Feb-2021

-

-

4

Dr K P Krishnan

Independent Director

Member

20-Jan-2022

-

-

5

Arun Madhavan Kumar

Independent Director

Member

01-08-2022

-

-

Stakeholders' Relationship Committee

Whether the Stakeholders' Relationship Committee has a regular chairperson - Yes

Sr. No.

Name of the Director

Category

Chairperson/Membership

Date of Appointment

Date of Cessation

Remarks

1

Kalpana Morparia

Independent Director

Chairperson

01-Aug-2014

-

-

2

K Satish Reddy

Chairman

Member

10-May-1994

-

-

3

G V Prasad

Co-Chairman & MD

Member

30-Oct-2000

-

-

Risk Management Committee

Whether the Risk Management Committee has a regular chairperson - Yes

Sr. No.

Name of the Director

Category

Chairperson/Membership

Date of Appointment

Date of Cessation

Remarks

1

Shikha Sharma

Independent Director

Chairperson

31-Jan-2019

-

-

2

Sridar Iyengar

Independent Director

Member

22-Aug-2011

-

-

3

Leo Puri

Independent Director

Member

02-Feb-2021

-

-

4

Penny Wan

Independent Director

Member

28-Jan-2022

-

-

5

Arun Madhavan Kumar

Independent Director

Member

01-Aug-2022

10-Jan-2023

-

Nomination, Governance and Compensation Committee (Nomination and Remuneration Committee)

Whether the Nomination, Governance and Compensation Committee has a regular chairperson - Yes

Sr.

Name of the Director

Category

Chairperson/Membership

Date of Appointment

Date of Cessation

Remarks

No.

1

Kalpana Morparia

Independent Director

Chairperson

02-Feb-2021

-

-

Dr K P Krishnan

Independent Director

Member

20-Jan-2022

-

-

3

Arun Madhavan

Independent Director

Member

10-Jan-2023

-

-

Kumar

4

Allan Oberman

Independent Director

Member

01-Apr-2021

06-Jan-2023

Ceased to be a member due to

resignation as Director w.e.f Jan

6, 2023

KUMAR RANDHIR SINGH

Digitally signed by

KUMAR RANDHIR SINGH Date: 2023.04.20 17:21:04 +05'30'

Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a regular chairperson - Yes

Sr.

Name of the Director

Category

Chairperson/Membership

Date of Appointment

Date of Cessation

Remarks

No.

1

Dr K P Krishnan

Independent Director

Chairperson

30-Oct-2022

-

-

2

Kalpana Morparia

Independent Director

Member

30-Oct-2022

-

-

2

K Satish Reddy

Chairman

Member

31-Oct-2013

-

-

3

G V Prasad

Co-Chairman & MD

Member

31-Oct-2013

-

-

Science, Technology and Operations Committee

Whether the Science, Technology and Operations Committee has a regular chairperson - Yes

Sr.

Name of the Director

Category

Chairperson/Membership

Remarks

No.

1

Leo Puri

Independent Director

Member

-

2

Penny Wan

Independent Director

Member

-

3

Allan Oberman

Independent Director

Member

Ceased to be a member of Science, technology and Operations committee w.e.f

Jan 6, 2023

  1. Meeting of Board of Directors

Date(s) of Meeting( Date(s) of

Maximum gap between

Whether requirement of

Total number of

No. of Directors

No: of Independent

previous quarter and current

any two consecutive (in

Quorum met (Yes/No)

Directors as on date

Present

Directors attending

quarter in chronological

number of days)

of meeting

the meeting

order)

28-10-2022

Yes

10

10

10

25-01-2023

88

Yes

9

9

7

20-03-2023

53

Yes

9

9

7

23-03-2023

2

Yes

9

9

7

  • Mr Prasad R Menon, term as a Director has ended on October 29, 2022 and he was present in the board meeting held on October 28, 2022. In the sheet "Annx 1 - Meeting of BOD". The XBRL utility is not accepting the actual number of directors present in the meeting held on October 28, 2022, as there is a validation error - "Please enter less then the No. of director mentioned in Annx 1 - Comp. of BOD. Therefore, Mr Menon's name has not been included in the "Total number of directors as on the date of meeting", "Number of Directors present (All Directors including Independent Director) and "No. of Independent Directors attending the meeting" columns. The directors who were present for the Board meeting held on October 28, 2022, were (Mr. K Satish Reddy, Mr G V Prasad, Mr Sridar Iyengar, Ms Kalpana Morparia, Mr Arun M Kumar, Ms Shikha Sharma, Mr Leo Puri, Dr K P Krishnan, Ms Penny Wan, Mr Allan Oberman and Mr Prasad R Menon)

IV. Meeting of Committees

Name of the committee

Date(s) of Meeting(

Maximum gap

Whether

No. of Directors Present

No. of Independent

Date(s) of previous

between any

requirement

Directors attending

quarter and current

two

of Quorum

the meeting

quarter in chronological

consecutive

met

order)

(Yes/No)

KUMAR RANDHIR SINGH

Digitally signed by

KUMAR RANDHIR SINGH Date: 2023.04.20 17:21:20 +05'30'

(in number of

days)

Audit Committee

28-10-2022

Yes

5

5

Audit Committee

25-01-2023

88

Yes

5

5

Audit Committee

24-03-2023

57

Yes

5

5

Nomination and Remuneration

27-10-2022

Yes

4

4

committee

Nomination and Remuneration

Yes

committee

24-01-2023

88

3

3

Nomination and Remuneration

Yes

committee

27-10-2022

3

1

Stakeholders' Relationship

Yes

Committee

24-01-2023

88

3

1

Stakeholders' Relationship

Yes

Committee

27-10-2022

3

1

Corporate Social Responsibility

Yes

Committee

24-01-2023

88

4

2

Corporate Social Responsibility

27-10-2022

Yes

5

5

Committee

Risk Management Committee

24-01-2023

88

Yes

4

4

Risk Management Committee

27-10-2022

Yes

4

4

Science, Technology and

Yes

Operations Committee

25-01-2023

89

2

2

Science, Technology and

28-10-2022

Yes

5

5

Operations Committee

V.

Related Party Transactions

Subject

Compliance status (Yes/No/NA)

Whether prior approval of audit committee obtained

Yes

Whether shareholder approval obtained for material RPT

Not Applicable

Whether details of RPT entered into pursuant to omnibus approval have been

Yes

reviewed by Audit Committee

Note: Pursuant to Regulation 23(5) of the SEBI (Listing Obligations and Disclosure Requirements), 2015 any transactions entered into between a holding company and its wholly owned subsidiary do not require approval of shareholders.

VI. Affirmations

Annexure I

1.

The composition of Board of Directors is in terms of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015. - Yes

2.

The composition of the following committees is in terms of SEBI(Listing Obligations and Disclosure

Requirements) Regulations, 2015

  1. Audit Committee - Yes
  2. Nomination, Governance and Compensation (Nomination & Remuneration) Committee - Yes
  3. Stakeholders' Relationship Committee - Yes
  4. Risk Management Committee (applicable to the top 100 listed entities) - Yes

KUMAR RANDHIR SINGH

Digitally signed by

KUMAR RANDHIR SINGH Date: 2023.04.20 17:21:33 +05'30'

  1. The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. - Yes
  2. The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.- Yes
  3. a. This report and/or the report submitted in the previous quarter has been placed before Board of Directors. - Yes b. Any comments/observations/advice of Board of Directors may be mentioned here:

The report for the quarter ended December 31, 2022 was placed before the Board of Directors at their meeting held on January 25, 2023 and this report for quarter and year ended March 31, 2023 is being placed before the Board of Directors at their forthcoming meeting to be held on May 10, 2023.

VII. Affirmations

Annexure I

Sr.

Particulars

Compliance Status

Web address

No

(Yes/No/NA)

1

Details of business

Yes

2

Terms and conditions of appointment of independent directors

Yes

3

Composition of various committees of board of directors

Yes

4

Code of conduct of board of directors and senior management personnel

Yes

5

Details of establishment of vigil mechanism/ Whistle Blower policy

Yes

6

Criteria of making payments to non-executive directors

Yes

7

Policy on dealing with related party transactions

Yes

8

Policy for determining 'material' subsidiaries

Yes

9

Details of familiarization programmes imparted to independent directors

Yes

10

Contact information of the designated officials of the listed entity who are responsible for

Yes

assisting and handling investor grievances

11

email address for grievance redressal and other relevant details

Yes

12

Financial results

Yes

13

Shareholding pattern

Yes

www.drreddys.com

14

Details of agreements entered into with the media companies and/or their associates

Yes

15

Schedule of analyst or institutional investor meet and presentations made

Yes

by the listed entity to analysts or institutional investors simultaneously with

submission to stock exchange

16

New name and the old name of the listed entity

Yes

17

Advertisements as per regulation 47 (1)

Yes

18

Credit rating or revision in credit rating obtained

Yes

19

Separate audited financial statements of each subsidiary of the listed entity

Yes

in respect of a relevant financial year

20

Whether company has provided information under separate section on its website as per

Yes

Regulation 46(2)

21

Materiality Policy as per Regulation 30

Yes

22

Dividend Distribution policy as per Regulation 43A (as applicable)

Yes

23

It is certified that these contents on the website of the listed entity are correct

Yes

KUMAR

Digitally signed by KUMAR

RANDHIR SINGH

RANDHIR SINGH Date: 2023.04.20 17:21:46 +05'30'

Attachments

Disclaimer

Dr. Reddy's Laboratories Limited published this content on 20 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2023 12:24:09 UTC.